Jace Jones, PhDAssociate Professor and Vice Chair for Education Associate Director of the Mass Spectrometry Center Department of Pharmaceutical Sciences at University of Maryland School of PharmacySpeaker
Profile
Dr. Jace W. Jones is an Associate Professor and Vice Chair of Education in the Department of Pharmaceutical Sciences, School of Pharmacy, University of Maryland. He is also the Associate Director of the Mass Spectrometry Center at the University of Maryland, School of Pharmacy. Dr. Jones received his B.S. degree from Whitworth University. He obtained his Ph.D. from the Department of Chemistry at the University of Washington under the mentorship of Dr. Frank Tureček. Following his PhD, he held a post-doc position in the laboratory of Dr. David R. Goodlett (University of Washington School of Pharmacy). He then spent several years in industry investigating the role of environmental contaminants on land resources and human health. Following his transition back to academics, he progressed from research scientist to research faculty under the mentorship of Dr. Maureen A. Kane (University of Maryland School of Pharmacy). In 2018, he started his independent laboratory as an Assistant Professor in the Department of Pharmaceutical Sciences at the University of Maryland School of Pharmacy. He was promoted to Associate Professor in the Summer of 2024. His research program seeks to understand the synergistic relationship between chemistry and biology, and how this profound interaction influences human health. Specifically, his lab is focused on developing mass spectrometry-based analytical platforms to investigate how structure impacts function for lipids and more recently oligonucleotides. He has been awarded the ASMS Research Award, the New Investigator Award from the American Association of Colleges of Pharmacy, and instructor of the year from the University of Maryland School of Pharmacy.
Agenda Sessions
Advances in LC separations, MS detection, and statistical analyses for characterizing oligonucleotide therapeutics for advancing new and generic drug development.
, 12:20pmView Session
